Line extension [Design Issues]

posted by Mikkabel – Belgium, 2018-01-24 11:17 (2078 d 06:41 ago) – Posting: # 18285
Views: 3,993

❝ Luckily you are not exceeding the recommended dose of the originator. Hence, I would opt for a simple line extension (T2 vs. 2×T1) since you can expect a better match than in BE – which is possible as well (T2 vs. 2×R).

❝ I don’t see how you could perform a dose-proportionality study with just two levels (zero degrees of freedom).

Hi Helmut,

Thank you for your quick reply!

I would also opt for a simple Pk study (T2 versus 2*T1) but do you have any idea to which guidelines I can refer to justify the rationale of the study and in particular the choice of the comparator (T1 instead of the originator).

Regarding the dose proportional study, I meant a PK study (T1 vs T2) and the results corrected by the dose should be compared.

Kind regards,

Complete thread:

UA Flag
 Admin contact
22,770 posts in 4,777 threads, 1,627 registered users;
9 visitors (0 registered, 9 guests [including 3 identified bots]).
Forum time: 18:59 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz